Early diagnosis of ovarian carcinoma: Is a solution in sight

Radiology

Volumn 259, Issue 2, 2011, Pages 329-345

  Lutz, Amelie M ^a   Willmann, Jürgen K ^a   Drescher, Charles W ^c   Ray, Pritha ^a   Cochran, Frank V ^a   Urban, Nicole ^c   Gambhir, Sanjiv S ^a,b  

^a Departments of Radiology   (United States)

^b Stanford University   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; FLUORODEOXYGLUCOSE F 18;

CANCER INCIDENCE; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DISEASE MARKER; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; FEMALE; FLUORESCENCE IMAGING; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CARCINOMA; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY;

CA-125 ANTIGEN; CONTRAST MEDIA; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; FEMALE; HUMANS; MASS SCREENING; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79955010368     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11090563     Document Type: Review

References (142)

1. Jemal A , Siegel R , Ward E Cancer statistics, 2010 CA Cancer J Clin 2010 ; 60 ( 5 ): 277-300
2. NIH Consensus Development Panel on Ovarian Cancer NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up JAMA 1995 ; 273 ( 6 ): 491-497
3. Merino MJ , Jaffe G Age contrast in ovarian pathology Cancer 1993 ; 71 ( 2 suppl ): 537-544 (Pubitemid 23021248)
4. Burkman RT Reproductive hormones and cancer: Ovarian and colon cancer Obstet Gynecol Clin North Am 2002 ; 29 ( 3 ): 527-540
5. Del Carmen MG Primary epithelial ovarian cancer: Diagnosis and management In: Educational Book of the American Society of Clinical Oncology Alexandria, Va : American Society of Clinical Oncology , 2006 ; 330-334
6. Modan B , Hartge P , Hirsh-Yechezkel G , et al Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation N Engl J Med 2001 ; 345 ( 4 ): 235-240 (Pubitemid 32695062)
7. Tavani A , Bosetti C , Dal Maso L , Giordano L , Franceschi S , La Vecchia C Influence of selected hormonal and lifestyle factors on familial propensity to ovarian cancer Gynecol Oncol 2004 ; 92 ( 3 ): 922-926 (Pubitemid 38251397)
8. Gates MA , Rosner BA , Hecht JL , Tworoger SS Risk factors for epithelial ovarian cancer by histologic subtype Am J Epidemiol 2010 ; 171 ( 1 ): 45-53
9. Stratton JF , Thompson D , Bobrow L , et al The genetic epidemiology of early-onset epithelial ovarian cancer: A populationbased study Am J Hum Genet 1999 ; 65 ( 6 ): 1725-1732 (Pubitemid 30468686)
10. Skírnisdóttir I , Garmo H , Wilander E , Holmberg L Borderline ovarian tumors in Sweden 1960-2005: Trends in incidence and age at diagnosis compared to ovarian cancer Int J Cancer 2008 ; 123 ( 8 ): 1897-1901
11. Ozols R , Rubin S , Thomas G , Robboy S Epithelial ovarian cancer In: Hoskin WJ , ed. Principles and practice of gynecologic oncology 4th ed. Philadelphia, Pa : Lippincott Williams & Wilkins , 2005 ; 895-987
12. Chan JK , Cheung MK , Husain A , et al Patterns and progress in ovarian cancer over 14 years Obstet Gynecol 2006 ; 108 ( 3 pt 1 ): 521-528 (Pubitemid 44337091)
13. Jarboe EA , Folkins AK , Drapkin R , Ince TA , Agoston ES , Crum CP Tubal and ovarian pathways to pelvic epithelial cancer: A pathological perspective Histopathology 2008 ; 53 ( 2 ): 127-138 (Pubitemid 352032762)
14. Crum CP , Drapkin R , Kindelberger D , Medeiros F , Miron A , Lee Y Lessons from BRCA: The tubal fimbria emerges as an origin for pelvic serous cancer Clin Med Res 2007 ; 5 ( 1 ): 35-44 (Pubitemid 350218778)
15. Kindelberger DW , Lee Y , Miron A , et al Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship Am J Surg Pathol 2007 ; 31 ( 2 ): 161-169 (Pubitemid 46175016)
16. Medeiros F , Muto MG , Lee Y , et al The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 2006 ; 30 ( 2 ): 230-236 (Pubitemid 43740193)
17. Callahan MJ , Crum CP , Medeiros F , et al Primary fallopian tube malignancies in BRCA- positive women undergoing surgery for ovarian cancer risk reduction J Clin Oncol 2007 ; 25 ( 25 ): 3985-3990 (Pubitemid 47477278)
18. Kosary CL Cancer of the ovary In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner MJ, eds. SEER survival monograph: Cancer survival among adults-U.S. SEER program, 1988-2001, patient and tumor characteristics. Publication no. 07-6215. Bethesda, Md: National Cancer Institute, 2007; 133-144.
19. Goff BA , Mandel LS , Drescher CW , et al Development of an ovarian cancer symptom index: Possibilities for earlier detection Cancer 2007 ; 109 ( 2 ): 221-227 (Pubitemid 46106236)
20. Andersen MR , Goff BA , Lowe KA , et al Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer Gynecol Oncol 2010 ; 116 ( 3 ): 378-383
21. Jacobs I , Stabile I , Bridges J , et al Multimodal approach to screening for ovarian cancer Lancet 1988 ; 1 ( 8580 ): 268-271 (Pubitemid 18052262)
22. Jacobs I Genetic, biochemical, and multimodal approaches to screening for ovarian cancer Gynecol Oncol 1994 ; 55 ( 3 pt 2 ): S22-S27
23. Urban N , McIntosh MW , Andersen M , Karlan BY Ovarian cancer screening Hematol Oncol Clin North Am 2003 ; 17 ( 4 ): 989-1005, ix (Pubitemid 37022154)
24. American College of Radiology Ovarian cancer screening In: ACR Appropriateness Criteria Reston, Va : National Cancer Institute , 2009
25. Vuento MH , Stenman UH , Pirhonen JP , Mäkinen JI , Laippala PJ , Salmi TA Signifi- cance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer Gynecol Oncol 1997 ; 64 ( 1 ): 141-146 (Pubitemid 27026972)
26. Einhorn N , Sjövall K , Knapp RC , et al Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer Obstet Gynecol 1992 ; 80 ( 1 ): 14-18
27. Karlan BY , Baldwin RL , Lopez-Luevanos E , et al Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: Implications for ovarian cancer screening Am J Obstet Gynecol 1999 ; 180 ( 4 ): 917-928 (Pubitemid 29200558)
28. Cannistra SA Cancer of the ovary N Engl J Med 2004 ; 351 ( 24 ): 2519-2529
29. Kilic G , Blankstein J , Kadanoff R Vertebral tuberculosis presenting with elevated CA-125 and weight loss mimicking ovarian malignancy; case report Eur J Gynaecol Oncol 2003 ; 24 ( 6 ): 561-562 (Pubitemid 37462582)
30. Leong CF , Cheong SK , Ng P , Amran AR Relapsed non-Hodgkin's lymphoma with high CA-125 mimicking ovarian tumour Hosp Med 2003 ; 64 ( 11 ): 686-687 (Pubitemid 38918416)
31. Sevinc A , Adli M , Kalender ME , Camci C Benign causes of increased serum CA-125 concentration Lancet Oncol 2007 ; 8 ( 12 ): 1054-1055 (Pubitemid 350182965)
32. Meyer T , Rustin GJ Role of tumour markers in monitoring epithelial ovarian cancer Br J Cancer 2000 ; 82 ( 9 ): 1535-1538 (Pubitemid 30204358)
33. Sturgeon CM , Duffy MJ , Stenman UH , et al National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers Clin Chem 2008 ; 54 ( 12 ): E11-e79 (Pubitemid 352777353)
34. Evans DG , Gaarenstroom KN , Stirling D , et al Screening for familial ovarian cancer: Poor survival of BRCA1/2 related cancers J Med Genet 2009 ; 46 ( 9 ): 593-597
35. Bell R , Petticrew M , Sheldon T The performance of screening tests for ovarian cancer: Results of a systematic review Br J Obstet Gynaecol 1998 ; 105 ( 11 ): 1136-1147 (Pubitemid 28526195)
36. Menon U , Gentry-Maharaj A , Hallett R , et al Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Lancet Oncol 2009 ; 10 ( 4 ): 327-340
37. Buys SS , Partridge E , Greene MH , et al Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial Am J Obstet Gynecol 2005 ; 193 ( 5 ): 1630-1639 (Pubitemid 41540458)
38. Coakley FV Staging ovarian cancer: Role of imaging Radiol Clin North Am 2002 ; 40 ( 3 ): 609-636 (Pubitemid 34765043)
39. Spencer JA A multidisciplinary approach to ovarian cancer at diagnosis Br J Radiol 2005 ; 78 ( spec no. 2 ): S94-S102 (Pubitemid 43019917)
40. Togashi K Ovarian cancer: The clinical role of US, CT, and MRI Eur Radiol 2003 ; 13 ( suppl 4 ): L87-L104 (Pubitemid 38008300)
41. Guerriero S , Ajossa S , Garau N , Piras B , Paoletti AM , Melis GB Ultrasonography and color Doppler-based triage for adnexal masses to provide the most appropriate surgical approach Am J Obstet Gynecol 2005 ; 192 ( 2 ): 401-406 (Pubitemid 40214971)
42. Alcázar JL , Ruiz-Perez ML , Errasti T Transvaginal color Doppler sonography in adnexal masses: Which parameter performs best? Ultrasound Obstet Gynecol 1996 ; 8 ( 2 ): 114-119 (Pubitemid 126720506)
43. Komatsu T , Konishi I , Mandai M , et al Adnexal masses: Transvaginal US and gadoliniumenhanced MR imaging assessment of intratumoral structure Radiology 1996 ; 198 ( 1 ): 109-115 (Pubitemid 26008250)
44. Granberg S , Norström A , Wikland M Tumors in the lower pelvis as imaged by vaginal sonography Gynecol Oncol 1990 ; 37 ( 2 ): 224-229 (Pubitemid 20182285)
45. Sassone AM , Timor-Tritsch IE , Artner A , Westhoff C , Warren WB Transvaginal sonographic characterization of ovarian disease: Evaluation of a new scoring system to predict ovarian malignancy Obstet Gynecol 1991 ; 78 ( 1 ): 70-76
46. DePriest PD , Shenson D , Fried A , et al A morphology index based on sonographic findings in ovarian cancer Gynecol Oncol 1993 ; 51 ( 1 ): 7-11 (Pubitemid 23339256)
47. Lerner JP , Timor-Tritsch IE , Federman A , Abramovich G Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system Am J Obstet Gynecol 1994 ; 170 ( 1 pt 1 ): 81-85 (Pubitemid 24084035)
48. Ferrazzi E , Zanetta G , Dordoni D , et al Transvaginal ultrasonographic characterization of ovarian masses: Comparison of five scoring systems in a multicenter study Ultrasound Obstet Gynecol 1997 ; 10 ( 3 ): 192-197 [Published correction appears in Ultrasound Obstet Gynecol 1998;11(1):v.]. (Pubitemid 27472453)
49. Twickler DM , Moschos E Ultrasound and assessment of ovarian cancer risk AJR Am J Roentgenol 2010 ; 194 ( 2 ): 322-329
50. Ueland FR , DePriest PD , Pavlik EJ , Kryscio RJ , van Nagell JR Jr Preoperative differentiation of malignant from benign ovarian tumors: The efficacy of morphology indexing and Doppler flow sonography Gynecol Oncol 2003 ; 91 ( 1 ): 46-50 (Pubitemid 37188592)
51. van Nagell JR Jr , DePriest PD , Ueland FR , et al Ovarian cancer screening with annual transvaginal sonography: Findings of 25,000 women screened Cancer 2007 ; 109 ( 9 ): 1887-1896 (Pubitemid 46668555)
52. Jacobs I , Oram D , Fairbanks J , Turner J , Frost C , Grudzinskas JG A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer Br J Obstet Gynaecol 1990 ; 97 ( 10 ): 922-929 (Pubitemid 20340625)
53. Tingulstad S , Hagen B , Skjeldestad FE , Halvorsen T , Nustad K , Onsrud M The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals Obstet Gynecol 1999 ; 93 ( 3 ): 448-452 (Pubitemid 29107011)
54. Morgante G , la Marca A , Ditto A , De Leo V Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses Br J Obstet Gynaecol 1999 ; 106 ( 6 ): 524-527 (Pubitemid 29245581)
55. Andersen ES , Knudsen A , Rix P , Johansen B Risk of malignancy index in the preoperative evaluation of patients with adnexal masses Gynecol Oncol 2003 ; 90 ( 1 ): 109-112 (Pubitemid 37338084)
56. Risum S , Høgdall C , Loft A , et al The diagnostic value of PET/CT for primary ovarian cancer-a prospective study Gynecol Oncol 2007 ; 105 ( 1 ): 145-149 (Pubitemid 46454333)
57. Fishman DA , Cohen L , Blank SV , et al The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer Am J Obstet Gynecol 2005 ; 192 ( 4 ): 1214-1221; discussion 1221-1222
58. Kurjak A , Kupesic S , Sparac V , Prka M , Bekavac I The detection of stage I ovarian cancer by three-dimensional sonography and power Doppler Gynecol Oncol 2003 ; 90 ( 2 ): 258-264 (Pubitemid 36952012)
59. Geomini PM , Coppus SF , Kluivers KB , Bremer GL , Kruitwagen RF , Mol BW Is threedimensional ultrasonography of additional value in the assessment of adnexal masses? Gynecol Oncol 2007 ; 106 ( 1 ): 153-159 (Pubitemid 46898583)
60. Alcázar JL , Castillo G Comparison of 2- dimensional and 3-dimensional power-Doppler imaging in complex adnexal masses for the prediction of ovarian cancer Am J Obstet Gynecol 2005 ; 192 ( 3 ): 807-812 (Pubitemid 40311273)
61. Jokubkiene L , Sladkevicius P , Valentin L Does three-dimensional power Doppler ultrasound help in discrimination between benign and malignant ovarian masses? Ultrasound Obstet Gynecol 2007 ; 29 ( 2 ): 215-225 (Pubitemid 46326596)
62. Alcázar JL , Jurado M Using a logistic model to predict malignancy of adnexal masses based on menopausal status, ultrasound morphology, and color Doppler findings Gynecol Oncol 1998 ; 69 ( 2 ): 146-150 (Pubitemid 28247001)
63. Valentin L , Sladkevicius P , Marsàl K Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors Obstet Gynecol 1994 ; 83 ( 3 ): 425-433
64. Levine D , Feldstein VA , Babcook CJ , Filly RA Sonography of ovarian masses: Poor sensitivity of resistive index for identifying malignant lesions AJR Am J Roentgenol 1994 ; 162 ( 6 ): 1355-1359 (Pubitemid 24187487)
65. Guerriero S , Alcazar JL , Ajossa S , et al Comparison of conventional color Doppler imaging and power Doppler imaging for the diagnosis of ovarian cancer: Results of a European study Gynecol Oncol 2001 ; 83 ( 2 ): 299-304 (Pubitemid 33033070)
66. Guerriero S , Alcazar JL , Coccia ME , et al Complex pelvic mass as a target of evaluation of vessel distribution by color Doppler sonography for the diagnosis of adnexal malignancies: Results of a multicenter European study J Ultrasound Med 2002 ; 21 ( 10 ): 1105-1111
67. Hamper UM , Sheth S , Abbas FM , Rosenshein NB , Aronson D , Kurman RJ Transvaginal color Doppler sonography of adnexal masses: Differences in blood flow impedance in benign and malignant lesions AJR Am J Roentgenol 1993 ; 160 ( 6 ): 1225-1228 (Pubitemid 23165539)
68. Jain KA Prospective evaluation of adnexal masses with endovaginal gray-scale and duplex and color Doppler US: Correlation with pathologic findings Radiology 1994 ; 191 ( 1 ): 63-67 (Pubitemid 24098202)
69. Kinkel K , Hricak H , Lu Y , Tsuda K , Filly RA US characterization of ovarian masses: A meta-analysis Radiology 2000 ; 217 ( 3 ): 803-811
70. Liu J , Xu Y , Wang J Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis of ovarian carcinoma Eur J Radiol 2007 ; 62 ( 3 ): 328-334 (Pubitemid 46783368)
71. D'Arcy TJ , Jayaram V , Lynch M , et al Ovarian cancer detected non-invasively by contrast-enhanced power Doppler ultrasound BJOG 2004 ; 111 ( 6 ): 619-622 (Pubitemid 38746248)
72. Testa AC , Timmerman D , Exacoustos C , et al The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: A preliminary study Ultrasound Obstet Gynecol 2007 ; 29 ( 5 ): 512-516 (Pubitemid 46826551)
73. Hennerici MG , Neuerburg-Heusler DN Physics and technology of ultrasound In: Vascular ultrasound: Clinical reference with case studies 2nd ed. Stuttgart, Germany : Thieme , 2006 ; 19-20
74. Fleischer AC , Lyshchik A , Jones HW Jr , et al Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: Preliminary findings J Ultrasound Med 2008 ; 27 ( 7 ): 1011-1018; quiz 1019-1021 (Pubitemid 351991174)
75. Polak JP Peripheral vascular sonography Philadelphia, Pa : Lippincott Williams & Wilkins , 2004
76. Lindner JR Microbubbles in medical imaging: Current applications and future directions Nat Rev Drug Discov 2004 ; 3 ( 6 ): 527-532 (Pubitemid 38807535)
77. Ordén MR , Jurvelin JS , Kirkinen PP Kinetics of a US contrast agent in benign and malignant adnexal tumors Radiology 2003 ; 226 ( 2 ): 405-410 (Pubitemid 36313427)
78. Marret H , Sauget S , Giraudeau B , et al Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses J Ultrasound Med 2004 ; 23 ( 12 ): 1629-1639; quiz 1641-1642 (Pubitemid 39586868)
79. Järvelä IY , Sladkevicius P , Tekay AH , Campbell S , Nargund G Intraobserver and interobserver variability of ovarian volume, gray-scale and color flow indices obtained using transvaginal three-dimensional power Doppler ultrasonography Ultrasound Obstet Gynecol 2003 ; 21 ( 3 ): 277-282 (Pubitemid 36390715)
80. Timmerman D , Van Calster B , Jurkovic D , et al Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors J Clin Oncol 2007 ; 25 ( 27 ): 4194-4200 (Pubitemid 47548558)
81. McDonald DM , Choyke PL Imaging of angiogenesis: From microscope to clinic Nat Med 2003 ; 9 ( 6 ): 713-725 (Pubitemid 36749220)
82. Yamamoto S , Konishi I , Mandai M , et al Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels Br J Cancer 1997 ; 76 ( 9 ): 1221-1227 (Pubitemid 27448021)
83. Willmann JK , Cheng Z , Davis C , et al Targeted microbubbles for imaging tumor angiogenesis: Assessment of whole-body biodistribution with dynamic micro-PET in mice Radiology 2008 ; 249 ( 1 ): 212-219
84. Willmann JK , Paulmurugan R , Chen K , et al US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice Radiology 2008 ; 246 ( 2 ): 508-518
85. Ellegala DB , Leong-Poi H , Carpenter JE , et al Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3 Circulation 2003 ; 108 ( 3 ): 336-341 (Pubitemid 36899026)
86. Willmann JK , Lutz AM , Paulmurugan R , et al Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo Radiology 2008 ; 248 ( 3 ): 936-944
87. Willmann JK , Kimura RH , Deshpande N , Lutz AM , Cochran JR , Gambhir SS Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides J Nucl Med 2010 ; 51 ( 3 ): 433-440
88. Pysz MA , Foygel K , Rosenberg J , Gambhir SS , Schneider M , Willmann JK Antiangiogenic cancer therapy: Monitoring with molecular US and a clinically translatable contrast agent (BR55) Radiology 2010 ; 256 ( 2 ): 519-527
89. Balan P Ultrasonography, computed tomography and magnetic resonance imaging in the assessment of pelvic pathology Eur J Radiol 2006 ; 58 ( 1 ): 147-155
90. Buist MR , Golding RP , Burger CW , et al Comparative evaluation of diagnostic methods in ovarian carcinoma with emphasis on CT and MRI Gynecol Oncol 1994 ; 52 ( 2 ): 191-198 (Pubitemid 24064369)
91. Massoud TF , Gambhir SS Molecular imaging in living subjects: Seeing fundamental biological processes in a new light Genes Dev 2003 ; 17 ( 5 ): 545-580 (Pubitemid 36307540)
92. Rabin O , Manuel Perez J , Grimm J , Wojtkiewicz G , Weissleder R An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles Nat Mater 2006 ; 5 ( 2 ): 118-122 (Pubitemid 43177900)
93. Hauth EA , Stattaus J , Debatin JF , Ruehm SG Magnetic resonance imaging in the diagnosis of benign and malignant pelvic tumors [in German] Rofo 2004 ; 176 ( 6 ): 817-828 (Pubitemid 38833011)
94. Yamashita Y , Torashima M , Hatanaka Y , et al Adnexal masses: Accuracy of characterization with transvaginal US and precontrast and postcontrast MR imaging Radiology 1995 ; 194 ( 2 ): 557-565
95. Reuter M , Steffens J , Schüppler U , et al Critical evaluation of the specificity of MRI and TVUS for differentiation of malignant from benign adnexal lesions Eur Radiol 1998 ; 8 ( 1 ): 39-44 (Pubitemid 128545030)
96. Hricak H , Chen M , Coakley FV , et al Complex adnexal masses: Detection and characterization with MR imaging-multivariate analysis Radiology 2000 ; 214 ( 1 ): 39-46 (Pubitemid 30019867)
97. Huber S , Medl M , Baumann L , Czembirek H Value of ultrasound and magnetic resonance imaging in the preoperative evaluation of suspected ovarian masses Anticancer Res 2002 ; 22 ( 4 ): 2501-2507 (Pubitemid 34857091)
98. Thomassin-Naggara I , Bazot M , Daraï E , Callard P , Thomassin J , Cuenod CA Epithelial ovarian tumors: Value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis Radiology 2008 ; 248 ( 1 ): 148-159
99. Nakayama T , Yoshimitsu K , Irie H , et al Diffusion-weighted echo-planar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: Usefulness of detecting keratinoid substances in mature cystic teratomas J Magn Reson Imaging 2005 ; 22 ( 2 ): 271-278 (Pubitemid 41045442)
100. Okada T , Harada M , Matsuzaki K , Nishitani H , Aono T Evaluation of female intrapelvic tumors by clinical proton MR spectroscopy J Magn Reson Imaging 2001 ; 13 ( 6 ): 912-917 (Pubitemid 32479950)
101. Caravan P , Ellison JJ , McMurry TJ , Lauffer RB Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications Chem Rev 1999 ; 99 ( 9 ): 2293-2352 (Pubitemid 30498114)
102. Schaffer BK , Linker C , Papisov M , et al MION-ASF: Biokinetics of an MR receptor agent Magn Reson Imaging 1993 ; 11 ( 3 ): 411-417
103. Wunderbaldinger P , Josephson L , Weissleder R Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles Bioconjug Chem 2002 ; 13 ( 2 ): 264-268 (Pubitemid 34267937)
104. Moore A , Josephson L , Bhorade RM , Basilion JP , Weissleder R Human transferrin receptor gene as a marker gene for MR imaging Radiology 2001 ; 221 ( 1 ): 244-250 (Pubitemid 32880396)
105. Choi H , Choi SR , Zhou R , Kung HF , Chen IW Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery Acad Radiol 2004 ; 11 ( 9 ): 996-1004 (Pubitemid 39220809)
106. Wiener EC , Konda SD , Wang S , Brechbiel M Imaging folate binding protein expression with MRI Acad Radiol 2002 ; 9 ( suppl 2 ): S316-S319 (Pubitemid 34857706)
107. Gambhir SS , Czernin J , Schwimmer J , Silverman DH , Coleman RE , Phelps ME A tabulated summary of the FDG PET literature J Nucl Med 2001 ; 42 ( 5 suppl ): 1S-93S (Pubitemid 32423895)
108. Hubner KF , McDonald TW , Niethammer JG , Smith GT , Gould HR , Buonocore E Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG) Gynecol Oncol 1993 ; 51 ( 2 ): 197-204
109. Kubik-Huch RA , Dörffler W , von Schulthess GK , et al Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma Eur Radiol 2000 ; 10 ( 5 ): 761-767 (Pubitemid 30321087)
110. Grab D , Flock F , Stöhr I , et al Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography Gynecol Oncol 2000 ; 77 ( 3 ): 454-459 (Pubitemid 30368567)
111. Rieber A , Nüssle K , Stöhr I , et al Preoperative diagnosis of ovarian tumors with MR imaging: Comparison with transvaginal sonography, positron emission tomography, and histologic findings AJR Am J Roentgenol 2001 ; 177 ( 1 ): 123-129 (Pubitemid 32578064)
112. Fenchel S , Grab D , Nuessle K , et al Asymptomatic adnexal masses: Correlation of FDG PET and histopathologic findings Radiology 2002 ; 223 ( 3 ): 780-788 (Pubitemid 34547598)
113. Kawahara K , Yoshida Y , Kurokawa T , et al Evaluation of positron emission tomography with tracer 18-fluorodeoxyglucose in addition to magnetic resonance imaging in the diagnosis of ovarian cancer in selected women after ultrasonography J Comput Assist Tomogr 2004 ; 28 ( 4 ): 505-516 (Pubitemid 38988818)
114. Castellucci P , Perrone AM , Picchio M , et al Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology Nucl Med Commun 2007 ; 28 ( 8 ): 589-595 (Pubitemid 47067045)
115. Yamamoto Y , Oguri H , Yamada R , Maeda N , Kohsaki S , Fukaya T Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography Int J Gynaecol Obstet 2008 ; 102 ( 2 ): 124-127
116. Dai SY , Hata K , Inubashiri E , et al Does three-dimensional power Doppler ultrasound improve the diagnostic accuracy for the prediction of adnexal malignancy? J Obstet Gynaecol Res 2008 ; 34 ( 3 ): 364-370 (Pubitemid 351832331)
117. Pauleit D , Stoffels G , Schaden W , et al PET with O-(2-18F-Fluoroethyl) -L-Tyrosine in peripheral tumors: First clinical results J Nucl Med 2005 ; 46 ( 3 ): 411-416 (Pubitemid 43093148)
118. Torizuka T , Kanno T , Futatsubashi M , et al Imaging of gynecologic tumors: Comparison of (11)C-choline PET with (18)F-FDG PET J Nucl Med 2003 ; 44 ( 7 ): 1051-1056 (Pubitemid 39663379)
119. Al-Jammaz I , Al-Otaibi B , Okarvi S , Amartey J Novel synthesis of 18F-fluorobenzene and pyridinecarbohydrazide-folates as potential PET radiopharmaceuticals J Labelled Comp Radiopharm 2006 ; 49 : 125-137 (Pubitemid 43384887)
120. Mathias CJ , Lewis MR , Reichert DE , et al Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals Nucl Med Biol 2003 ; 30 ( 7 ): 725-731 (Pubitemid 37123129)
121. Robinson MK , Doss M , Shaller C , et al Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti- HER2 diabody Cancer Res 2005 ; 65 ( 4 ): 1471-1478 (Pubitemid 40270176)
122. Grünberg J , Novak-Hofer I , Honer M , et al In vivo evaluation of 177Lu- and 67/64Culabeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors Clin Cancer Res 2005 ; 11 ( 14 ): 5112-5120 (Pubitemid 41003695)
123. Pichler BJ , Kolb A , Nägele T , Schlemmer HP PET/MRI: Paving the way for the next generation of clinical multimodality imaging applications J Nucl Med 2010 ; 51 ( 3 ): 333-336
124. Judenhofer MS , Catana C , Swann BK , et al PET/MR images acquired with a compact MR-compatible PET detector in a 7-T magnet Radiology 2007 ; 244 ( 3 ): 807-814 (Pubitemid 47292092)
125. Brewer MA , Utzinger U , Barton JK , et al Imaging of the ovary Technol Cancer Res Treat 2004 ; 3 ( 6 ): 617-627 (Pubitemid 40023552)
126. Brewer M , Utzinger U , Silva E , et al Fluorescence spectroscopy for in vivo characterization of ovarian tissue Lasers Surg Med 2001 ; 29 ( 2 ): 128-135 (Pubitemid 32808300)
127. Utzinger U , Brewer M , Silva E , et al Reflectance spectroscopy for in vivo characterization of ovarian tissue Lasers Surg Med 2001 ; 28 ( 1 ): 56-66 (Pubitemid 32052603)
128. Löning M , Diddens H , Küpker W , Diedrich K , Hüttmann G Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX Cancer 2004 ; 100 ( 8 ): 1650-1656 (Pubitemid 38456342)
129. Olivier RI , Lubsen-Brandsma MA , Verhoef S , van Beurden M CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer Gynecol Oncol 2006 ; 100 ( 1 ): 20-26 (Pubitemid 41815044)
130. Hogg R , Friedlander M Biology of epithelial ovarian cancer: Implications for screening women at high genetic risk J Clin Oncol 2004 ; 22 ( 7 ): 1315-1327 (Pubitemid 41079847)
131. Kauff ND , Hurley KE , Hensley ML , et al Ovarian carcinoma screening in women at intermediate risk: Impact on quality of life and need for invasive follow-up Cancer 2005 ; 104 ( 2 ): 314-320 (Pubitemid 40993258)
132. Bazot M , Nassar-Slaba J , Thomassin-Naggara I , Cortez A , Uzan S , Daraï E MR imaging compared with intraoperative frozensection examination for the diagnosis of adnexal tumors; correlation with final histology Eur Radiol 2006 ; 16 ( 12 ): 2687-2699 (Pubitemid 44823922)
133. Takeuchi M , Matsuzaki K , Uehara H , Nishitani H Malignant transformation of pelvic endometriosis: MR imaging findings and pathologic correlation RadioGraphics 2006 ; 26 ( 2 ): 407-417 (Pubitemid 43515314)
134. Milam RA , Milam MR , Iyer RB Detection of early-stage ovarian cancer by FDG-PETCT in a patient with BRCA2-positive breast cancer J Clin Oncol 2007 ; 25 ( 35 ): 5657-5658
135. Kurman RJ , Shih IM The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory Am J Surg Pathol 2010 ; 34 ( 3 ): 433-443
136. Sohaib SA , Mills TD , Sahdev A , et al The role of magnetic resonance imaging and ultrasound in patients with adnexal masses Clin Radiol 2005 ; 60 ( 3 ): 340-348 (Pubitemid 40260268)
137. Testa AC , Timmerman D , Van Belle V , et al Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components Ultrasound Obstet Gynecol 2009 ; 34 ( 6 ): 699-710
138. Deshpande N , Ren Y , Foygel K , Rosenberg J , Willmann JK Tumor angiogenic marker expression levels during tumor growth: Longitudinal assessment with molecularly targeted microbubbles and US imaging Radiology 2011 ; 258 ( 3 ): 804-811
139. Pysz MA , Willmann JK Targeted contrastenhanced ultrasound: An emerging technology in abdominal and pelvic imaging Gastroenterology 2011; doi:10.1053/j.gastro. 2011.01.027.
140. Hobbs SK , Monsky WL , Yuan F , et al Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment Proc Natl Acad Sci U S A 1998 ; 95 ( 8 ): 4607-4612 (Pubitemid 28207960)
141. Kamaly N , Kalber T , Thanou M , Bell JD , Miller AD Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging Bioconjug Chem 2009 ; 20 ( 4 ): 648-655
142. Wang ZJ , Boddington S , Wendland M , Meier R , Corot C , Daldrup-Link H MR imaging of ovarian tumors using folatereceptor- targeted contrast agents Pediatr Radiol 2008 ; 38 ( 5 ): 529-537